RA Chem Pharma Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
512
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
4
- Investments
-
1
RA Chem Pharma General Information
Description
Manufacturer of active pharmaceutical ingredients (APIs) intended for the pharmaceutical, biotechnology and medical device industries. The company engages in the production of active pharmaceutical ingredients (APIs) along with other formulations and clinical research, enabling clients to receive a wide spectrum of products used in the development and manufacturing of various pharmaceuticals.
Contact Information
Website
www.rachempharma.comCorporate Office
- Plot No: 45 Silicon Valley
- Madhapur, Telanagana 500081
- India
Corporate Office
- Plot No: 45 Silicon Valley
- Madhapur, Telanagana 500081
- India
RA Chem Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
RA Chem Pharma Comparisons
Industry
Financing
Details
RA Chem Pharma Competitors (9)
One of RA Chem Pharma’s 9 competitors is Inke (Castellbisbal), a Private Equity-Backed company based in Les Corts, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Inke (Castellbisbal) | Private Equity-Backed | Les Corts, Spain | ||||
| Vasudha Pharma | Corporation | Hyderabad, India | ||||
| Symed Labs | Formerly PE-Backed | Hyderabad, India | ||||
| Chempro Pharma Pvt. | Corporation | Mumbai, India | ||||
| La Chandra Pharmalab Private | Corporation | Ahmedabad, India |
RA Chem Pharma Patents
RA Chem Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230270716-A1 | Glycopyrrolate oral film and it's process | Inactive | 28-Jul-2020 | ||
| WO-2022023994-A1 | Glycopyrrolate oral film and it's process | Inactive | 28-Jul-2020 | ||
| US-11214551-B2 | One pot synthesis of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid, a key intermediate of zilpaterol | Inactive | 27-Apr-2018 | ||
| US-20210238146-A1 | One pot synthesis of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid, a key intermediate of zilpaterol | Active | 27-Apr-2018 | ||
| WO-2019207591-A1 | One pot synthesis of 4-(1,2-dihydro-2-oxobenzo[d]imidazol-3-yl)butanoic acid, a key intermediate of zilpaterol | Inactive | 27-Apr-2018 | C07D235/26 |
RA Chem Pharma Signals
RA Chem Pharma Investments (1)
RA Chem Pharma’s most recent deal was a Buyout/LBO with ZCL Chemicals for . The deal was made on 09-Mar-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| ZCL Chemicals | 09-Mar-2021 | Buyout/LBO | Other Pharmaceuticals and Biotechnology |
RA Chem Pharma FAQs
-
When was RA Chem Pharma founded?
RA Chem Pharma was founded in 2003.
-
Where is RA Chem Pharma headquartered?
RA Chem Pharma is headquartered in Madhapur, India.
-
What is the size of RA Chem Pharma?
RA Chem Pharma has 512 total employees.
-
What industry is RA Chem Pharma in?
RA Chem Pharma’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is RA Chem Pharma a private or public company?
RA Chem Pharma is a Private company.
-
What is RA Chem Pharma’s current revenue?
The current revenue for RA Chem Pharma is .
-
Who are RA Chem Pharma’s competitors?
Inke (Castellbisbal), Vasudha Pharma, Symed Labs, Chempro Pharma Pvt., and La Chandra Pharmalab Private are some of the 9 competitors of RA Chem Pharma.
-
When was RA Chem Pharma acquired?
RA Chem Pharma was acquired on 01-Nov-2022.
-
Who acquired RA Chem Pharma?
RA Chem Pharma was acquired by Cohance Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process